Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.
about
Mutant-specific BRAF and CD117 immunocytochemistry potentially facilitate risk stratification for papillary thyroid carcinoma in fine-needle aspiration biopsy specimens.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Mutant-specific BRAF and CD117 ...... e aspiration biopsy specimens.
@en
Mutant-specific BRAF and CD117 ...... e aspiration biopsy specimens.
@nl
type
label
Mutant-specific BRAF and CD117 ...... e aspiration biopsy specimens.
@en
Mutant-specific BRAF and CD117 ...... e aspiration biopsy specimens.
@nl
prefLabel
Mutant-specific BRAF and CD117 ...... e aspiration biopsy specimens.
@en
Mutant-specific BRAF and CD117 ...... e aspiration biopsy specimens.
@nl
P2093
P2860
P1433
P1476
Mutant-specific BRAF and CD117 ...... e aspiration biopsy specimens.
@en
P2093
Huanwen Wu
Junliang Lu
Qingli Zhu
Yufeng Luo
Yuxin Jiang
Zhilan Meng
Zhiyong Liang
P2860
P2888
P304
P356
10.1007/S13277-015-3837-9
P577
2015-08-04T00:00:00Z